Dr Ronald L Dalman (Stanford Medicine, US) discusses the impact of diabetes on patients with abdominal aortic aneurysm (AAA) disease and the different indications and treatment strategies compared to non-diabetic patients.
1. What percentage of AAA patients in your practice are diabetics?
2. How and why is AAA disease different in diabetics?
3. How do these differences impact treatment strategies?
4. Can outcomes with diabetics ever be comparable to non-diabetics?
Filmed on site at Veith 2019 by Radcliffe Vascular.
Interviewer: Liam O'Neill
Videographer: Tom Green